Tocilizumab dose of 8mg/kg up to a maximum dose of 800mg to be administered as a single dose only. Tocilizumab is administered as an intravenous infusion over 60 minutes on day -1 of conditioning. Clinical Trials
3 recruitingIntervention
Phase 22Phase 31
Showing 1–3 of 3 trials
Recruiting
Phase 3
Use of Tocilizumab (TCZ) to prevent acute graft versus host disease (GVHD) randomized trial
Acute graft versus host disease (GVHD) post HLA-matched allogeneic haematopoietic progenitor cell transplantation (HPCT)
Royal Brisbane and Women's Hospital110 enrolled1 locationACTRN12614000266662
Recruiting
Phase 2
Use of Tocilizumab (TCZ) to prevent acute graft versus host disease (GVHD)
Acute graft versus host disease (GVHD) post HLA-matched allogeneic haematopoietic progenitor cell transplantation (HPCT)
Royal Brisbane and Women's Hospital18 enrolled1 locationACTRN12614000212651
Recruiting
Phase 2
Use of Tocilizumab (TCZ) to prevent acute graft versus host disease (GVHD)
Acute graft versus host disease (GVHD) post HLA-matched allogeneic haematopoietic progenitor cell transplantation (HPCT)
Royal Brisbane and Women's Hospital48 enrolled1 locationACTRN12612000726853